The FDA has approved a combination tablet consisting of sitagliptin and metformin hydrochloride (Janumet XR, Merck) to treat type 2 diabetes. The once-daily agent is indicated as an adjunct to diet and exercise to improve glycemic control.
Abstract: Merck.
eMedia - Endocrinology
RT @PracticalWisdom: “Excessive medical testing is a major problem in the U.S.” Dr. Sah http://t.co/1QDm9W3tQ0 HT @RichDuszak
Retinoid-induced epidermal hyperplasia in human skin organ culture: inhibition with soy extract and soy isoflavones http://t.co/Kexkb4HGN7
Interview with Jonas Salk, developer of the polio vaccine (interview dates April 28, 1974) - http://t.co/QfM5Os2wxI
Facebook
